The Efficacy of Combined Intrathecal Morphine and PENG Block on Postoperative Pain in Hip Arthroplasty

Launched by BEZMIALEM VAKIF UNIVERSITY · Mar 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how well a combination of two pain management techniques—low-dose intrathecal morphine (a pain medicine given through the spine) and a specific nerve block called the Pericapsular Nerve Group (PENG) block—works in managing pain after hip surgery. Researchers want to see if this combination can reduce the amount of morphine needed and improve recovery compared to using either method alone. The trial is currently looking for participants aged 18 to 90 who are undergoing hip replacement surgery and meet specific health criteria.

If you join the study, you will receive one of the pain management treatments during your surgery and will be monitored for 48 hours afterward to evaluate your pain levels and recovery. To be eligible, you should not have a history of opioid addiction, certain serious health conditions, or allergies to the medications being used. This trial aims to help improve pain management strategies for patients undergoing hip surgeries, making recovery smoother and more comfortable.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged between 18 and 90 years
• • American Society of Anesthesiologists (score ranging from 1 to 4)
• • Anterior hip arthroplasties
• Exclusion Criteria:
• • Patients with a history of opioid addiction
• • Individuals under the age of 18
• • Those aged 90 and above
• • Allergies to morphine, fentanyl, bupivacaine, or tramadol
• • Coagulopathy
• • Infection at the injection site
• • Severe cardiac, renal, or hepatic dysfunction
• • Cases unable to provide informed consent
• • Body Mass Index \>40 kg/m2
• • Known neurological or anatomical deficits in the lower extremities
• • Patients requiring a transition from spinal anesthesia to general anesthesia